AORT
Price
$21.53
Change
+$0.17 (+0.80%)
Updated
Oct 14 closing price
Capitalization
1.12B
14 days until earnings call
Intraday BUY SELL Signals
UTMD
Price
$74.79
Change
+$0.08 (+0.11%)
Updated
Oct 14 closing price
Capitalization
236.42M
Intraday BUY SELL Signals
Interact to see
Advertisement

AORT vs UTMD

AORT vs UTMD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AORT vs. UTMD commentary
Oct 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Hold and UTMD is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AORT with price predictions
Oct 14, 2026

AORT sees its Stochastic Oscillator climbs out of oversold territory

On October 12, 2026, the Stochastic Oscillator for AORT moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 53 instances where the indicator left the oversold zone. In 42 of the 53 cases the stock moved higher in the following days. This puts the odds of a move higher at over 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AORT's RSI Oscillator exited the oversold zone, 17 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.

The Moving Average Convergence Divergence (MACD) for AORT just turned positive on October 14, 2026. Looking at past instances where AORT's MACD turned positive, the stock continued to rise in 36 of 48 cases over the following month. The odds of a continued upward trend are 75%.

Following a +2.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where AORT advanced for three days, in 222 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

Bearish Trend Analysis

The 10-day moving average for AORT crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 54%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AORT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

The Aroon Indicator for AORT entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. AORT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.511) is normal, around the industry mean (10.930). P/E Ratio (104.680) is within average values for comparable stocks, (100.178). Projected Growth (PEG Ratio) (4.200) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.603) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AORT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
a Summary for UTMD with price predictions
Oct 14, 2026

Momentum Indicator for UTMD turns positive, indicating new upward trend

UTMD saw its Momentum Indicator move above the 0 level on October 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 101 similar instances where the indicator turned positive. In 66 of the 101 cases, the stock moved higher in the following days. The odds of a move higher are at 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

UTMD moved above its 50-day moving average on September 14, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where UTMD advanced for three days, in 145 of 250 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

Bearish Trend Analysis

The 10-day RSI Indicator for UTMD moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In 12 of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Moving Average Convergence Divergence Histogram (MACD) for UTMD turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 31 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

UTMD broke above its upper Bollinger Band on September 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.937) is normal, around the industry mean (5.011). P/E Ratio (22.726) is within average values for comparable stocks, (163.451). Projected Growth (PEG Ratio) (5.980) is also within normal values, averaging (4.456). UTMD has a moderately high Dividend Yield (0.017) as compared to the industry average of (0.005). P/S Ratio (6.549) is also within normal values, averaging (56.074).

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. UTMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UTMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

FUNDAMENTALS RATINGS
AORT vs UTMD: Fundamental Ratings
AORT
UTMD
OUTLOOK RATING
1..100
6831
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9175
PRICE GROWTH RATING
1..100
8142
P/E GROWTH RATING
1..100
8815
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTMD's Valuation (19) in the Medical Specialties industry is significantly better than the same rating for AORT (92). This means that UTMD’s stock grew significantly faster than AORT’s over the last 12 months.

UTMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AORT (100). This means that UTMD’s stock grew similarly to AORT’s over the last 12 months.

UTMD's SMR Rating (75) in the Medical Specialties industry is in the same range as AORT (91). This means that UTMD’s stock grew similarly to AORT’s over the last 12 months.

UTMD's Price Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for AORT (81). This means that UTMD’s stock grew somewhat faster than AORT’s over the last 12 months.

UTMD's P/E Growth Rating (15) in the Medical Specialties industry is significantly better than the same rating for AORT (88). This means that UTMD’s stock grew significantly faster than AORT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTUTMD
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
57%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
62%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
65%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
58%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 1 day ago
58%
Declines
ODDS (%)
Bearish Trend 7 days ago
67%
Bearish Trend 10 days ago
51%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
62%
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
COMPARISON
Comparison
Oct 15, 2026
Stock price -- (AORT: $21.53 vs. UTMD: $74.79)
Brand notoriety: AORT and UTMD are both not notable
AORT represents the Medical/Nursing Services, while UTMD is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AORT: 77% vs. UTMD: 78%
Market capitalization -- AORT: $1.12B vs. UTMD: $236.42M
AORT [@Medical/Nursing Services] is valued at $1.12B. UTMD’s [@Pharmaceuticals: Other] market capitalization is $236.42M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $146.54B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.59B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green while UTMD’s FA Score has 2 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • UTMD’s FA Score: 2 green, 3 red.
According to our system of comparison, UTMD is a better buy in the long-term than AORT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 4 TA indicator(s) are bullish while UTMD’s TA Score has 3 bullish TA indicator(s).

  • AORT’s TA Score: 4 bullish, 3 bearish.
  • UTMD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AORT is a better buy in the short-term than UTMD.

Price Growth

AORT (@Medical/Nursing Services) experienced а -0.37% price change this week, while UTMD (@Pharmaceuticals: Other) price change was +1.82% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.79%. For the same industry, the average monthly price growth was -7.51%, and the average quarterly price growth was -14.87%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.96%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +3.79%.

Reported Earning Dates

AORT is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Medical/Nursing Services (-4.79% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-0.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
AORT
Daily Signal:
Gain/Loss:
UTMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MYCF25.020.02
+0.10%
State Street My2026 Corporate Bond ETF (MYCF)
FDHY47.55-0.27
-0.56%
Fidelity Enhanced High Yield ETF (FDHY)
RECS45.53-0.39
-0.85%
Columbia Research Enhanced Core ETF (RECS)
BCGD26.25-0.34
-1.30%
Baron Global Durable Advantage ETF (BCGD)
CAGE29.24-0.67
-2.22%
Calamos Autocallable Growth ETF (CAGE)

UTMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with CERS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
+0.11%
CERS - UTMD
50%
Loosely correlated
-0.88%
TMCI - UTMD
47%
Loosely correlated
-1.46%
INMD - UTMD
47%
Loosely correlated
-0.17%
ITGR - UTMD
44%
Loosely correlated
+0.02%
IART - UTMD
43%
Loosely correlated
-4.87%
More